Global med-tech company Surgalign Holdings, Inc. has acquired equity interest in Inteneural Networks Inc. Surgalign focuses on uplifting the standards of surgery and is building out its digital health platform to drive transformation across the surgical landscape. The deal helps Surgalign use Inteneural’s AI technology for autonomously segmenting and identifying neural structures in medical images. This is tremendously helpful in identifying pathological states. 

Surgalign acquired 42% of Inteneural equity for $21 million, consisting of $5 million in cash, $10.6 million in promissory notes and $5.4 million in stocks. Surgalign will have the ability to acquire the remaining 58% of INN in three equal tranches through 2027. The complete acquisition of Inteneural will cost Surgalign $79 million.

Inteneural Networks Inc. or INI specialises in artificial intelligence and big data learning to analyse brain imaging. This Chicago-based medical high-tech company Professor Paul Lewicki and Dr Kris Siemionow in 2017. Professor Lewicki has in-depth knowledge of data mining and big data learning whereas Dr Siemionow has expertise in high-tech imaging databases and surgical applications. Surgalign’s products are available throughout the USA and in 50+ countries.